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Porcine  epidemic  diarrhea  virus  (PEDV),  a  coronavirus  discovered  more  than  40 years  ago,  regained  noto-
riety recently  by  its  devastating  outbreaks  in East  Asia  and  the Americas,  causing  substantial  economic
losses  to the  swine  husbandry.  The  virus replicates  extensively  and  almost  exclusively  in  the  epithelial
cells  of  the  small  intestine  resulting  in  villus  atrophy,  malabsorption  and  severe  diarrhea.  Cellular  entry
of  this  enveloped  virus  is  mediated  by the  large  spike  (S)  glycoprotein,  trimers  of  which mediate  virus
attachment  to the  target  cell and  subsequent  membrane  fusion.  The  S protein  has  a multidomain  archi-
tecture  and has been  reported  to bind  to carbohydrate  (sialic  acid)  and  proteinaceous  (aminopeptidase
N)  cell  surface  molecules.  PEDV  propagation  in  vitro  requires  the  presence  of  trypsin(-like)  proteases  in
the culture  medium,  which  capacitates  the  fusion  function  of the  S protein.  Here  we  review  the  current
data  on PEDV  entry  into  its host  cell,  including  therein  our  new  observations  regarding  the  functional
role  of  the sialic acid  binding  activity  of  the S protein  in  virus  infection.  Moreover,  we  summarize  the
recent  progress  on  the  proteolytic  activation  of  PEDV  S proteins,  and discuss  factors  that may  determineirus entry
ialic acid
ialic acid binding
eceptor interaction
tissue  tropism  of  PEDV  in  vivo.
© 2016  The  Authors.  Published  by  Elsevier  B.V.  This  is  an open  access  article  under  the  CC  BY  license
(http://creativecommons.org/licenses/by/4.0/).embrane fusion
roteolytic activation
irus tropism
ontents
1. Introduction  . . . .  .  . .  . . . .  . . .  .  . . . .  . . .  .  . . .  .  . . .  . . . . .  . . . . . . . . . .  . . . . . . .  .  . . . . . .  .  . . . . . .  . . . . . .  . . .  .  . . . . .  . . . . .  . . .  .  . . . .  . . . .  . . . . . . .  . . . . . . .  .  . . .  .  .  .  . . .  .  . . . . .  . . . .  .  . . .  . .  . 118
1.1. Coronaviruses  infecting  swine  . . .  . . . .  . . . .  . . .  .  . . .  . .  .  .  . . . . . .  .  . . . . .  .  . .  . . .  . . .  .  . . .  . .  .  . . . . . .  .  .  . . . .  . .  . . . . . . .  . . . .  . . .  . . .  . . . . .  .  .  . . . . . . . . .  .  . . .  .  .  .  . . . . .  . .  .  . 118
1.2. PEDV  epidemiology  .  . . .  .  . . .  .  . . . .  . . .  . .  .  .  . .  .  .  . .  .  .  . . .  .  .  .  . . . .  . .  . . . . .  .  .  .  . . . .  .  . .  . . .  . .  .  . . . .  .  . .  . . . . . . .  . . .  .  .  . . . .  . . .  . . . .  .  . .  . . . . .  . . . . . .  .  .  .  .  . .  . . . . . . .  .  . . . . .  118
1.3.  PEDV  pathogenesis .  .  .  . . .  .  . . .  .  . . .  . . . .  . . .  .  . . .  . . . .  .  . . .  . . .  . . . .  .  . .  . .  .  . .  . . .  . . .  . . . . . .  .  . . . . . . .  .  . . . . .  .  .  . . .  . . . . .  . . .  . . .  . . . . . . . . .  . .  . . . . . . . . . .  .  .  .  . . .  . .  . .  .  . .  .118
2.  Structure,  function  and  antigenicity  of the  PEDV  S protein . . .  . . .  .  .  . . . . .  . .  . . .  . .  .  . .  .  .  . . . .  .  . . . . . . .  .  .  . .  . . .  . . .  . . . . .  . .  . . . . . . .  .  . . . . .  .  . . . .  .  . . . .  .  . .  .  .  .  .  . . .  . . . .118
3.  PEDV  receptor  usage  . . . .  . . .  .  . . .  .  . . .  .  . . .  . . . . . . . .  . .  .  .  . . .  . . . . . . .  . . . . . .  .  . .  . . . .  . .  .  . . . . . .  . .  . . .  . .  .  . . . . . .  .  . . . . .  . . .  . . . . . . .  . . .  .  . . . .  .  .  . . . . .  . . .  .  .  .  . . . .  . . .  . .  .  . . . . . .  119
4.  Structural  and  functional  assessment  of the PEDV  spike  protein  N-domain  .  . .  . .  . . .  . .  . . . . . . .  .  . . .  . . . . .  . . .  . . .  . . . .  . . . . .  .  . . .  .  . . . . .  .  . . . . .  . .  .  .  .  .  . . .  .  . . .  . . . 120
4.1.  N-domains  in spike  proteins  of  alphacoronaviruses  . . .  . . .  .  .  . . . . . . . . . .  . . . . .  . .  .  . . . . . . . .  . . . . .  . . .  . .  . . .  .  .  . . .  . . . . . . . . . .  .  .  . . .  .  . .  .  . .  . . .  .  . . . . .  .  . . . .  . . . 120
4.2. The  caDR13-PEDV  spike  N-domain  is  dispensable  for  virus  propagation  in cell culture  . . .  . .  . . . . .  . .  . . .  . .  .  .  . . .  .  . . .  . . . . . . .  . . . .  .  .  .  .  . .  . . . .  . . . .  .  . 122
4.3.  Sialic  acid  binding  capacity  of  S protein  differs  among  PEDV  strains  .  . . . . .  . .  .  . . . .  .  . . . .  .  . .  . . . . . .  .  . . . .  . . . .  .  . . . . . . .  .  . . . .  .  . .  . .  . . . . . .  . . . .  .  .  .  .  . .  .  . .  122
4.4. Sialic  acid  binding  activity  of  the PEDV S protein  facilitates  cell  entry  .  .  . . . . .  . . .  . . . . .  .  . . . .  . . .  . .  . . .  . . .  . .  .  . . . .  .  .  .  .  . . . . . .  .  . . . .  .  . .  .  . .  . . . .  .  . . . . . .  . 123
4.5. Functional  role  of  the  PEDV N-domain  .  . . .  .  . . . .  .  . . .  . . . . . .  .  . . . .  .  . . . .  . . . . . . . . .  . .  .  . . . . .  .  .  .  . .  . . .  .  . . . .  . .  .  . . . .  . .  .  . . .  .  . . . .  .  . .  .  .  .  .  . . . .  .  . . . . .  . .  .  .  .  .  . . .  .  123
5.  Requirements  for  proteolytic  spike  protein  activation  . . .  .  . . . . . . .  .  . . .  . .  .  . . .  . . .  . . . .  . .  .  . . . .  . .  . . .  . .  .  . .  . . .  .  . . . . . .  .  . .  . . . .  .  .  . . . . . . .  . . . . . .  .  . .  .  . .  .  . .  .  . . . . .  . .  .  124
5.1. PEDV  propagation  in  cell  culture  depends  on  supplemental  trypsin  . . . . . . .  . . . . . .  . . . . . . .  .  . . . .  . . .  . .  . . .  . . .  . . .  .  . . .  .  .  . . . . . .  . . .  .  .  .  . . .  .  . . . . . .  . .  .  . .  .  124
5.2. Cleavage  required  to activate  spike  fusion  function  . . . .  . .  .  . . . .  .  . . . . .  . .  . . . . . . .  .  .  . .  . . .  . . .  . . . . .  . .  . .  . . .  . .  .  .  . . . . . . . .  . . . . . .  .  .  .  .  . . . . . . .  .  . .  .  .  .  . . . .  .  . .  125
5.3.  Cleavage  as  tropism  determinant. . . . . .  . . . .  .  . . .  .  . . .  . . . .  . . .  . . . .  .  . . .  .  .
Acknowledgements  . . . .  .  . . . .  . . .  . . .  . . .  .  . . .  .  . . . .  . . . .  . . .  . . . .  . . . .  . . . . . . . . . .  .  . . .
References  .  . .  .  . .  . . .  . .  . .  . . . .  . . .  .  . . .  .  . . . . . .  . . . . . . . . . . .  .  . . .  .  . . .  . . . .  . . .  . . . .  . . . . .
∗ Corresponding author.
E-mail address: b.j.bosch@uu.nl (B.-J. Bosch).
ttp://dx.doi.org/10.1016/j.virusres.2016.05.031
168-1702/© 2016 The Authors. Published by Elsevier B.V. This is an open access article u . . . . . . .  . . . .  . . . . . . . .  . . . . . . .  . . .  . . . .  .  . . . . .  . . . . . . . . .  . . .  .  .  .  . . . . . . . . . . . .  . .  .  .  .  .  .  .  .125
 . .  . . .  . . . .  .  . . . . .  . . . . .  . . .  . . . .  . . . .  .  .  . . . . . .  . . . . . . .  .  .  .  . .  . . . . . . .  .  .  .  .  . .  .  . . . . .  . .  . . .  125
 .  .  . .  . . . . . .  . . . . .  . .  .  .  . . .  .  . . .  . . . .  . . . . . . .  . .  .  . . . . . . . .  .  . . .  .  .  .  .  . .  . . . . . . . . . .  .  .  .  .  . .  . 125
nder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
1 earch 
1
o
p
r
p
a
i
(
e
a
s
n
h
i
s
t
t
w
t
P
r
i
b
f
1
n
v
p
i
r
c
a
r
s
s
t
i
g
c
v
(
m
l
v
s
t
p
g
t
i
e
c
h
B
a
i
t
c
218 W.  Li et al. / Virus Res
. Introduction
Porcine epidemic diarrhea virus (PEDV) is the causative agent
f porcine epidemic diarrhea (PED), an enteric disease affecting
igs of all ages. The disease is characterized by acute watery diar-
hea, dehydration and vomiting, with high mortality in neonatal
iglets. Devastating outbreaks of PED in East Asia (since 2010)
nd in North America (since 2013) have revitalized the research
nto this porcine coronavirus that was ﬁrst identiﬁed in 1978
Stevenson et al., 2013). PEDV primarily replicates in the villous
nterocytes of the small intestine. Its entry into host cells is medi-
ted by the spike (S) glycoprotein that is exposed on the virion
urface. This key entry factor is considered the main determi-
ant of viral host and tissue tropism. Moreover, the S protein is
ighly immunogenic and the main target for neutralizing antibod-
es. Understanding this protein’s function will thus aid the design of
trategies against this enteric swine coronavirus and is fundamen-
al to our understanding of its epidemiology and pathogenesis. In
his review, following a brief and general introduction on PEDV,
e will describe the structure and function of the spike glycopro-
ein. In particular, we will report the generation of a recombinant
EDV virus harboring a large deletion in the S protein’s N-terminal
egion for studies to assess the role of sialic acid binding activ-
ty of PEDV S in infection. Finally we will discuss the mechanism
y which the S protein is proteolytically activated for membrane
usion.
.1. Coronaviruses infecting swine
PEDV is a member of the Coronaviridae family (subfamily Coro-
avirinae, family Coronaviridae, order Nidovirales). This family of
iruses comprises a large group of enveloped viruses with a
ositive-sense RNA genome of up to 32 kilobases. Coronaviruses
nfect a broad range of mammalian and avian hosts and can cause
espiratory, enteric, hepatic and neurological disease. Pathogenic
oronaviruses are found in farm animals as well as in humans
nd have demonstrated potential to cross the host-species bar-
ier. Two zoonotic coronaviruses – the severe acute respiratory
yndrome coronavirus (SARS-CoV) and the Middle East respiratory
yndrome coronavirus (MERS-CoV) – have emerged over the last
wo decades, both causing severe and often fatal respiratory disease
n humans. Coronaviruses have recently been subdivided into four
enera: Alphacoronavirus, Betacoronavirus (lineages A–D), Gamma-
oronavirus and Deltacoronavirus (de Groot et al., 2013). Pathogenic
iruses in each genus include transmissible gastroenteritis virus
TGEV), human coronavirus (HCoV) 229E and HCoV-NL63 (-CoV),
ouse hepatitis virus (MHV, -CoV, lineage A), SARS-CoV (-CoV,
ineage B), MERS-CoV (-CoV, lineage C), avian infectious bronchitis
irus (IBV, -CoV) and porcine deltacoronavirus (PDCoV, -CoV). In
wine ﬁve coronaviruses have been identiﬁed, representing three of
he four genera. PEDV, TGEV and the natural TGEV deletion mutant
orcine respiratory virus (PRCoV) belong to the Alphacoronavirus
enus. TGEV mainly infects epithelial cells from the small intes-
ine and causes enteritis and fatal diarrhea in piglets; it is clinically
ndistinguishable from PEDV. Unlike TGEV, PRCoV mostly infects
pithelial cells of the respiratory tract and alveolar macrophages
ausing a mild or often subclinical respiratory disease. The porcine
emagglutinating encephalomyelitis virus (PHEV) belongs to the
etacoronavirus genus; it targets respiratory and neuronal tissues
nd causes vomiting, wasting disease and neurological disorders
n seronegative piglets (Straw et al., 2006). The recently iden-
iﬁed PDCoV of the Deltacoronavirus genus has enteric tropism
ausing mild to moderate disease in young piglets (Jung et al.,
015).226 (2016) 117–127
1.2. PEDV epidemiology
PED was not detected in swine until the 1970s. The ﬁrst PED out-
break in swine was  recognized in England in 1971. Seven years later
the etiological agent was  identiﬁed as a coronavirus and ofﬁcially
named as PEDV (Pensaert and De Bouck, 1978). PED was preva-
lent throughout Europe causing sporadic, localized outbreaks in
the 1980s, 1990s and in subsequent years (Martelli et al., 2008).
PED was  ﬁrst reported in Asia in 1982 and since then it has had an
increasingly great economic impact on the Asian swine industry.
Particularly since 2010, devastating outbreaks have been reported
in China and other Asian countries causing up to 100% mortality in
suckling piglets (Li et al., 2012; Puranaveja et al., 2009; Sun et al.,
2012). PEDV entered the United States (US) for the ﬁrst time in
April 2013 and this virulent strain rapidly spread across the US to
36 states, as well as to other countries in North- and South-America,
including Canada (Pasick et al., 2014), Mexico (Vlasova et al., 2014),
the Dominican Republic, Colombia and Peru (Ojkic et al., 2015;
Oka et al., 2014). A less virulent PEDV strain has been detected in
the US characterized by small genomic insertions and deletions (S
INDEL strain) in the viral spike glycoprotein. Since 2014, PEDV has
reemerged in Europe including Germany (Hanke et al., 2015), Italy,
Austria (Steinrigl et al., 2015), The Netherlands, Belgium (Theuns
et al., 2015), Portugal (Mesquita et al., 2015), France (Grasland et al.,
2015) and Ukraine (Dastjerdi et al., 2015).
1.3. PEDV pathogenesis
PEDV mainly infects and replicates in villous enterocytes of the
small intestine (duodenum, jejunum and ileum) (Debouck et al.,
1981; Ducatelle et al., 1981, 1982). Infection results in destruc-
tion of the intestinal epithelium with subsequent villus shortening
causing watery diarrhea that lasts for about a week. Other clini-
cal symptoms include vomiting, anorexia and fever. Pigs of all ages
are susceptible, but symptoms are most severe in suckling piglets
of less than one week old with mortality rates often approaching
100%. Fatality rates in weaned pigs are much lower (1–3%) while
mortality has not been observed among fattening pigs (Hou et al.,
2007). Many studies indicate that PEDV does not replicate outside
the intestinal tract, though PEDV was detected in a recent study by
RT-PCR and IHC in other organs of experimentally infected piglets
including lung, liver, kidney and spleen (Park and Shin, 2014).
2. Structure, function and antigenicity of the PEDV S
protein
The PEDV S protein is the key protein responsible for virus entry
into the target cell. It mediates the essential functions of receptor
binding and subsequent fusion of the viral and cellular membranes
during cell entry, thereby releasing the viral nucleocapsid into the
cytoplasm. The PEDV S protein is a ±1383-residues long glycopro-
tein of 180–200 kilodalton in size. Trimers of these S proteins form
the club-shaped, ±20 nm long projections (spikes) on the virion
surface that provide the coronavirus its typical crown-like appear-
ance on electron micrographs (Pensaert and De Bouck, 1978). Like
other CoV spike proteins, PEDV S is a type I membrane glyco-
protein with an N-terminal signal peptide, a large extracellular
region, a single transmembrane domain and a short cytoplasmic
tail (Fig. 1). The ectodomain of coronavirus spike proteins can be
divided into two  domains with distinct functions: the N-terminal S1
subunit responsible for receptor binding and the C-terminal mem-
brane anchored S2 domain responsible for membrane fusion. The
border between the S1 (residues 1–726, CV777 numbering [GB:
AF353511]) and S2 (residues 727–1383) subunit can be deduced
from the sequence alignment with alphacoronavirus S proteins (e.g.
W.  Li et al. / Virus Research 226 (2016) 117–127 119
Fig. 1. Schematic presentation of spike proteins of PEDV and related alphacoronaviruses. a) The PEDV S protein. The S1 and S2 subunits, the signal peptide (SP, residues
1–18),  the N-terminal domain (N, residue 19–233), regions containing neutralizing epitopes (COE, residues 499–638 and S1D, residues 636–789), the fusion peptide (FP;
residues 891–908), two heptad repeat regions (HR1, residues 978–1117 and HR2, residues 1274–1313), the transmembrane domain (TM, residues 1324–1346; predicted by
TMHMM  server) and predicted N-glycosylation sites (; predicted by the NetNGlyc server) are indicated. b) N-terminal domains (N) in the spike proteins of PEDV and related
alphacoronaviruses. Schematic representations of the spike proteins are shown of a number of viruses belonging to Alphacoronavirus genus including PEDV strain CV777 (GB:
AAK38656.1), TGEV strain Purdue P115 (GB: ABG89325.1), PRCoV strain ISU-1 (GB: ABG89317.1), FECV strain UU23 (GB: ADC35472.1), FIPV strain UU21 (GB: ADL71466.1),
H B: ALK
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Receptor interaction plays a crucial role in the cell and tissueCoV-NL63 (GB: YP 003767.1), HCoV-229E related bat CoV with one N domain (G
CoV-229E strain inf-1 (GB: NP 073551.1). Spike proteins are drawn to scale and al
equence is indicated in orange.
ype I feline and canine coronaviruses) of which the S1-S2 junction
s clearly demarcated by the presence of a furin protease cleav-
ge site (de Haan et al., 2008). Recent elucidation of the cryo-EM
tructure of a betacoronavirus spike trimer demonstrated a mod-
lar S1 protein architecture with four discrete domains (Walls
t al., 2016), two of which may  interact with host receptors and
ence serve as a receptor binding domain for betacoronaviruses.
wo independently folding domains have been assigned in the S1
ubunit of alphacoronaviruses that can interact with host cell sur-
ace molecules: an N-terminal domain (TGEV S residues 1–244)
hat can exhibit sialic acid binding activity, and a more C-terminal
omain (TGEV S residues 506–655) that can interact with a pro-
ein receptor (Reguera et al., 2012). Relative to S1, the S2 subunit
s more conserved in amino acid sequence and contains the typical
tructural features found in class I viral fusion proteins including a
ydrophobic fusion peptide (FP), heptad repeat regions (HR1 and
R2) and a C-terminal trans membrane (TM) region (Fig. 1). As
or all class I fusion proteins, membrane fusion is started by the
xposure and insertion of the FP into the target cell membrane,
fter which the fusion protein jackknives such that the antiparal-
el HR1 and HR2 regions form a stable six-helix bundle structure.
uring this transition, the fusion peptide and the transmembrane
omain come into close proximity enabling the fusion of the viral
nd cellular membrane (Eckert and Kim, 2001). A key feature of
he coronavirus S protein is the proteolytic priming of the fusion
otential by host proteases that can occur at the S1/S2 junction as
ell as adjacent to the fusion peptide within the S2 region at the S2′
osition (Belouzard et al., 2009; Yamada and Liu, 2009). The PEDV
pike proteins on the virion are uncleaved, yet they undergo this28775.1), HCoV-229E related bat CoV with two N domains (GB: ALK28765.1) and
 at the position of the conserved fusion peptide indicated by the dashed line. Signal
proteolytic requirement for fusion during the entry stage (Wicht
et al., 2014b Shirato et al., 2011a,b).
Exerting critical functions in cell entry, the coronavirus S protein
is the main target for humoral immunity. A recent study demon-
strated that immunization of pregnant sows with the PEDV S1
protein could provide passive immunity against PEDV to suckling
piglets through colostrum and milk (Oh et al., 2014). The S pro-
tein ectodomain contains at least two  neutralizing B-cell epitopes
(Chang et al., 2002; Cruz et al., 2006; Zhang et al., 2016). One of
the neutralizing epitopes maps to a domain homologous to the col-
lagenase resistant fragment (CO-26 K) of the TGEV S protein and
was coined ‘CO-26 K equivalent’ (COE) domain for PEDV (residues
499–638). The CO-26 K fragment in TGEV S harbors the receptor
binding domain to which most neutralizing antibodies are directed
(Godet et al., 1994). Analogous to TGEV, immunization of mice with
the PEDV S COE region elicited virus neutralizing antibodies (Chang
et al., 2002). The S1D region (residues 636–789) in PEDV S con-
tains another neutralizing epitope and spans the S1-S2 junction.
Two non-neutralizing B-cell epitopes (SS2: 748-YSNIGVCK-755 and
SS6: 764-LQDGQVKI-771) have been identiﬁed within this region,
just downstream of the predicted S1-S2 junction (Sun et al., 2008)
(Fig. 1a).
3. PEDV receptor usagetropism of coronaviruses as well as in pathogenesis and cross-
species transmission. Coronaviruses can bind to a wide range of
proteinaceous and carbohydrate cell surface molecules via their
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pike proteins. PEDV has been reported to utilize the aminopep-
idase N protein (APN, also known as CD13) as a functional
eceptor (Li et al., 2007). APN serves as a receptor for multi-
le alphacoronaviruses, including the canine coronavirus type II,
eline coronavirus type II, TGEV and PRCoV and human coronavi-
us 229E (HCoV-229E) (Delmas et al., 1992; Yeager et al., 1992).
t is, however, not a universal receptor for these viruses as the
uman coronavirus NL63 (HCoV-NL63) uses angiotensin convert-
ng enzyme 2 (ACE2) for its entry (Hofmann et al., 2005). APN is a
50 kDa glycosylated type II transmembrane protein that is highly
bundant on the apical membrane of mature enterocytes (Mina-
sorio, 2008). It was termed ‘moonlighting enzyme’ referring to its
ultiple biological functions, including peptide metabolism, cell
otility and adhesion (Mina-Osorio, 2008). Several lines of evi-
ence support the view that APN is a functional receptor for PEDV:
) in a virus overlay protein binding assay a ∼150 kDa protein was
dentiﬁed as a PEDV binding protein in swine testis (ST) cells and
nterocytes, and this interaction could be blocked by antibodies
gainst porcine APN (pAPN); ii) APN overexpression in otherwise
on-permissive cell lines (i.c. Madin Darby canine kidney and ST
ells) conferred susceptibility of these cells to PEDV infection (Nam
nd Lee, 2010); iii) PEDV S1 was shown to biochemically interact
ith soluble APN in a dot-blot assay and with cell surface expressed
PN in a FACS assay (Liu et al., 2015 Deng et al., 2016); iv) preincuba-
ion of cells with pAPN antibodies or a pAPN-binding peptide prior
o inoculation interfered with PEDV infection (Li et al., 2007; Meng
t al., 2014), and v) transgenic mice expressing pAPN appeared
usceptible to PEDV infection (Park et al., 2015). The APN bind-
ng domain was recently shown to reside within a domain in the
-terminal half of PEDV S1 (residues 477–629), corresponding to
he RBD of TGEV S1 (residues 505–655). Intriguingly, though sug-
ested to share the same receptor, the two aromatic residues within
he extending loops of the TGEV RBD known to be critical for APN
inding are not conserved in the PEDV RBD, indicating a different
ode of receptor interaction. African green monkey Vero cell lines
re historically used for isolation and propagation of PEDV strains.
et, these cells do not express APN as inferred from mass spectrom-
try analyses of the Vero cell proteome (Guo et al., 2014; Li et al.,
007; Shirato et al., 2011a,b; Zeng et al., 2015) and the lack of mRNA
ranscripts in these cells (our own data, not shown), indicating that
ther receptors may  be involved in PEDV entry into these cells.
PEDV exhibits promiscuous binding to cellular receptors (Liu
t al., 2015). Unlike TGEV, PEDV was shown to interact with and uti-
ize human APN as a functional receptor. Moreover, PEDV can infect
ultiple cell lines in vitro from different species besides porcine
ncluding bat and primate (human and non-human). Intriguingly,
he genome sequence and genome organization of PEDV are more
elated to bat alphacoronaviruses than to other viruses from the
ame genus suggesting that interspecies transmission between bats
nd pigs, perhaps via an intermediate host, may  have occurred
Woo  et al., 2012). The ability of PEDV to infect cells of multiple
pecies suggests that the virus – similar to MERS-CoV – utilizes
volutionarily conserved host cell components as receptors thereby
ncreasing the potential for cross-species and potentially zoonotic
ransmission (Gallagher and Perlman, 2013; Raj et al., 2013). Apart
rom its interaction with APN, PEDV is able to bind sialic acids
Deng et al., 2016; Liu et al., 2015). Several coronaviruses from the
lpha-, beta- and gammacoronavirus genus have been shown to
ind to sialic acids, a feature variably required for virus infection
n cell culture depending on the particular (Schwegmann-Weßels
nd Herrler, 2006). This lectin activity resides within the N-
erminal domain of their spike protein. Notably, betacoronaviruses
ithin the lineage A1 including HCoV-OC43, bovine coronavirus
BCoV) and PHEV use (acetylated) sialic acid as a primary receptor.
ther coronaviruses can bind to sialoglycoconjugates in addition
o their primary protein receptor. The APN-recruiting TGEV S1226 (2016) 117–127
can bind to sialic acids (N-acetylneuraminic acid [Neu5Ac] and
N-glycolylneuraminic acid [Neu5Gc]) via its N-terminal region
(residues 21–244) (Krempl et al., 1997; Reguera et al., 2012;
Schultze et al., 1996). The sialic acid binding activity appears dis-
pensable for TGEV infection in cell culture but enhances infection
under shorter inoculation conditions (Schwegmann-Wessels et al.,
2011). PEDV was shown to have hemagglutination (HA) activity
using rabbit erythrocytes, but this HA activity was  only observed
after pretreatment of the virus with trypsin or neuraminidase (Park
et al., 2010). PEDV lacks the HE protein that is responsible for
the HA activity of beta-coronaviruses like MHV, HCoV-OC43 and
BCoV. Because in other hemagglutinating coronaviruses lacking an
HE protein such as IBV and TGEV the HA activity resides in the S
protein, in PEDV this activity is also likely to occur in this protein.
Chang et al. demonstrated that PEDV S1 could bind to bovine and
porcine mucins as shown by dot-blot hybridization assay. Further-
more, they used a glycan array screen to identify which type(s) of
sugar was the most favored by PEDV S1, observing that Neu5Ac
shows the highest binding afﬁnity (Liu et al., 2015). The sialic acid
binding activity of PEDV was shown very recently to occur in the
N-terminal region of its spike protein (residues 1–320), analogous
to other sialic acid-binding coronaviruses (Deng et al., 2016). How-
ever, it is unknown whether sialic acid binding by the S protein can
facilitate entry of PEDV into cells.
4. Structural and functional assessment of the PEDV spike
protein N-domain
4.1. N-domains in spike proteins of alphacoronaviruses
For a number of alphacoronaviruses the loss of the S protein N-
domain correlates with a loss of enteric tropism (Fig. 1b). i) The
clearest example of this phenomenon is TGEV that displays a dual
tropism targeting the respiratory and enteric tract. On the other
hand, PRCoV, a natural deletion variant of TGEV lacking the S pro-
tein N-domain, lost its enteric tropism and mainly replicates in
the respiratory tract (Cox et al., 1990; Sanchez et al., 1992); ii)
feline coronaviruses come in two  pathotypes, the clinically mild or
asymptomatic enteric FECV and the highly pathogenic, systemically
replicating FIPV. FIPV is thought to originate from FECV by muta-
tion and seems to have lost its tropism for enterocytes (Desmarets
et al., 2013). Sequencing analysis of multiple FECV and FIPV ﬁeld
strains indicates that, contrary to enteric FECV ﬁeld strains, some
FIPV strains (e.g. strains UU16 and UU21, Fig. 1b) have a large dele-
tion in the N-domain; iii) clinical isolates of HCoV-229E encode
a relatively short spike protein of 1173 residues in length due to
the apparent lack of the N-domain (Farsani et al., 2012). Recently,
bat coronaviruses related to HCoV-229E have been isolated from
hipposiderid bats, some of them encoding unusual large spike gly-
coproteins of 1571–1582 residues in length (Corman et al., 2015).
Intriguingly, PSI-BLAST analysis indicates that these 229E-related
bat coronaviruses carry two  consecutive N-domain homologs in
the ﬁrst 425 residues part of their S protein − which we  designated
N1 and N2 − with 32% and 35% amino acid sequence identity to
the N-domain of the HCoV-NL63 S protein, respectively (Fig. 1b).
Other 229E-related bat coronaviruses isolated from bats of the
same genus carry shorter spike proteins (±1362 a.a.) that harbor
a single N-domain (Fig. 1b). The HCoV-229E and a related alpaca
coronavirus lacking an N-domain in its spike protein have respira-
tory tropism and are not generally associated with gastro-enteritis
(Esper et al., 2010), whereas most bat coronaviruses have enteric
tropism (Drexler et al., 2014). Together the above examples sug-
gest a role of the alphacoronavirus spike N-domain for replication
in the intestinal tract. In case of TGEV, the loss of enteric tropism
was speciﬁcally associated with the loss of the sialic binding activ-
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Fig. 2. Generation and characterization of a recombinant PEDV (PEDV-SN) with a large 215-residues long deletion in the N-terminal region of the S protein. a) Amino
acid  sequence alignment of the N-terminal region of the spike proteins of PEDV variants. The N-terminal region (residues 1–294) of the spike protein of the cell culture
adapted DR13 strain (caDR13; GB: JQ023162.1) was aligned with the corresponding spike protein sequences of the caDR13 PEDV-SN recombinant described in this study
and  two earlier described PEDV variants with deletions in the N-domain − PC177 (GB: AKR05184.1) and Tottori2 (GB: BAR92898.1) − as well as of the PEDV-GDU strain (GB:
KU985229) and PEDV-UU strain (GB: KU985229). Alphahelical (‘H’) and betasheet (’E’) secondary structural elements were predicted using the JPRED4 server (http://www.
compbio.dundee.ac.uk/jpred/). Conserved residues and gaps are indicated in the alignment using the ‘*’ and ‘-‘ symbols, respectively. Signal peptide and cysteine residues are
marked  in grey and black, respectively. b) Schematic representation of the recombinant PEDV genomes carrying the wildtype spike (SWT) gene (PEDV-SWT-GFP) or the SN
gene (PEDV-SN-GFP). For both viruses, the S proteins carried a C-terminal Flag-tag peptide (VQDYKDDDDK) and the ORF3 gene was substituted by the GFP  gene (Wicht et al.,
2014b). Left panel displays pictures of Vero cells infected with PEDV-SWT-GFP or PEDV-SN-GFP taken by ﬂuorescence microscopy. c) Western-blot analysis of the S protein
of  recombinant PEDV-SWT-GFP and PEDV-SN-GFP. Recombinant viruses propagated in Vero (CCL81) cells in the absence of trypsin were semi-puriﬁed by sedimentation
through a 20% (w/w)  sucrose cushion, subjected to Western blot analysis, after which S proteins were detected with an anti-Flag monoclonal antibody (Sigma). d) Multi-step
growth  kinetics of PEDV-SWT-GFP and PEDV-SN-GFP. Vero cells were inoculated with recombinant PEDV (MOI = 0.01) for 3 h in the absence of trypsin, after which the
inoculum was  replaced by fresh culture medium, following a previously described procedure (Wicht et al., 2014b). Virus infectivity in culture medium was determined at
different times p.i. (4, 12, 24, 36, 48, 60, 72, 96 or 120 h p.i.) by a quantal assay on Vero cells from which TCID50 values were calculated.
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Fig. 3. PEDV virions of different strains vary in their hemagglutination activity. a) Virions of the PEDV-GDU strain but not of the PEDV-UU or PEDV-caDR13 strain are able to
agglutinate human erythrocytes. The HA assay was  performed according to a previously described procedure (Park et al., 2010) and the inﬂuenza A virus (A/California/07/2009)
was  taken along as a positive control. Two-fold serial dilutions of viruses (start dilution 1 × 107 TCID50/ml) were made in 50 l phosphate buffered saline supplemented
with  0.1% bovine serum albumin. Neuraminidase (from Arthrobacter ureafaciens, Sigma, cat.no. 10269611001) treated (10 mU ml−1 at 37 ◦C for 2 h) or mock treated human
erythrocytes were washed with phosphate buffered saline. 50 l erythrocyte suspension (0.5%) was  mixed with 50 ul of each virus dilution in V-shaped 96 wells plates
and  incubated for 2 h on ice after which the wells were photographed. Virus dilutions are indicated above the plate. Wells positive for hemagglutination are encircled in
red.  b) The Fc-tagged S1 protein of the PEDV-GDU strain but not that of the PEDV-UU or PEDV-caDR13 strain is able to agglutinate human erythrocytes. To enhance the
sensitivity of the S1-based hemagglutination assay, we  premixed 5 g of S1-Fc proteins with 1 ul of protein A-coupled, 200nm-sized nanoparticles (nano-screenMAG-Protein
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a beads; Chemicell GmbH, cat.no. 4503-1) to increase the avidity of S1-Fc proteins fo
ctodomain (A/California/07/2009, GB: ACP41953.1) fused to the human Fc portion
EDV-S1-Fc was 5 g and two-fold serial dilutions of virus-nanoparticle mixtures w
ty that resides in this domain. A TGEV mutant with a four amino
cids deletion in its S protein N-domain that resulted in a loss
f hemagglutinating activity displayed reduced enteropathogenic-
ty (Krempl et al., 1997). How sialic acid binding activity in this
-terminal spike domain inﬂuences enteric tropism of these alpha-
oronaviruses remains to be resolved. It has been hypothesized
) that surface-bound sialoglycoconjugates may  protect the virus
rom hostile conditions in the stomach, ii) that virion binding to
ucins may  prevent the loss of viruses by intestinal peristalsis,
nd iii) that binding to mucins may  allow the viruses to pass the
hick mucus barrier thereby gaining access to their intestinal tar-
et cells (Krempl and Herrler, 2001). In the following paragraphs
$4.2–$4.4) we describe our recent data regarding the role of the N-
erminal domain and the sialic-acid binding activity of the S protein
n PEDV infection in cell culture.
.2. The caDR13-PEDV spike N-domain is dispensable for virus
ropagation in cell culture
Since N-domain deletions had been observed in spike proteins
f natural variants of different alphacoronaviruses, we attempted
o generate a recombinant PEDV with a similar deletion using
ur previously described reverse genetics system based on the
ell culture adapted PEDV DR13 strain (caDR13) (Li et al., 2013).
e designed a PEDV recombinant with a 215 residues long
-terminal spike deletion (residues 19–233) analogous to the dele-
ion observed in the spike protein of the FIPV strain UU21 (GB:
DC35472.1). The deletion was introduced into the previously
escribed pPEDV-ORF3/GFP transfer vector and recombinant
iruses were generated using targeted recombination (Li et al.,
013). Recombinant viruses, designated PEDV-SWT-GFP and PEDV-
N-GFP, could be rescued, plaque puriﬁed and their identity was
onﬁrmed by Sanger sequencing and Western blot analysis (data
ot shown and Fig. 2c). Propagation of both viruses was compared
n Vero cells. Intriguingly, PEDV-SN-GFP exhibited growth char-
cteristics similar to that of PEDV-SWT-GFP indicating that deletionc acids on the erythrocyte surface. The inﬂuenza A virus hemagglutinin glycoprotein
-HA-Fc) was taken along as a positive control. The start dilution of IAV-HA-Fc and
ested as decribed above.
of the N-domain did not impair propagation of the PEDV caDR13
strain in vitro (Fig. 2d).
4.3. Sialic acid binding capacity of S protein differs among PEDV
strains
We  assessed the sialic acid binding activity of different strains
of PEDV using an HA assay. Surprisingly, viruses of different strains
displayed remarkable differences in their ability to hemaggluti-
nate human erythrocytes. Apart from the cell culture adapted DR13
strain we used two  recent PEDV ﬁeld isolates from China (strain
GDU) and The Netherlands (strain UU, S INDEL type). PEDV-GDU
was able to agglutinate human erythrocytes. Hemagglutination
was dependent on sialic acids since pretreatment of the erythro-
cytes with bacterial neuraminidase abolished hemagglutination of
PEDV-GDU as well as of inﬂuenza virus A (IAV) that was taken
along as a positive control. In contrast to PEDV-GDU, the PEDV-
caDR13 as well as the PEDV-UU strain did not show detectable
HA activity (Fig. 3a). We  conﬁrmed the strain dependent HA activ-
ity using a recombinant S1 protein-based HA assay. S1 proteins of
different PEDV strains C-terminally fused to the human IgG Fc por-
tion (S1-Fc) were expressed in HEK–293 T cells and subsequently
afﬁnity-puriﬁed by using protein A sepharose beads as described
before (Raj et al., 2013). The PEDV-GDU S1-Fc − expressed as
dimers due to the disulphide-linkage of the Fc moiety − was not
able to hemagglutinate human erythrocytes presumably due to
a too low avidity. To improve the sialic acid binding avidity and
increase the sensitivity of the hemagglutination assay, the S1-Fc
proteins were complexed via their Fc portion with protein A-
coupled, 200nm-sized nanoparticles. We  demonstrated that these
GDU-S1-Fc loaded nanoparticles were able to hemagglutinate ery-
throcytes. This indicates that the multivalent interactions between
these S1-Fc loaded nanoparticles and sialic acids increases the avid-
ity of binding to erythrocytes. Multimerization on nanoparticles
may  hence provide a general and versatile method to increase
the avidity of receptor-ligand interactions. The similarly multimer-
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Fig. 4. Dependency of PEDV on cell surface sialic acids for infection of Vero cells varies between strains. a) Vero cells were pretreated with PBS or PBS containing neuraminidase
(100  mU  ml−1; Sigma, cat.no. 10269611001) at 37 ◦C for 2 h. Cells were subsequently inoculated with PEDV-GDU, PEDV-UU or inﬂuenza A virus (IAV-WSN) (Baggen et al.,
2016) at a multiplicity of infection of 5, 1 or 5, respectively, for 1 h at 37 ◦C in the presence of trypsin. Inoculum was removed and cells were washed thrice with fresh medium
and  further incubated at 37 ◦C in medium supplemented with 1% fetal calf serum. At 14 h p.i. cells were ﬁxed and infected cells were visualized by immunoﬂuorescence
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as  calculated by counting the infected cells in 10 x microscopic ﬁelds. Statistical s
xperiments were repeated three times, and representative images are shown.
zed caDR13- or UU-S1-Fc proteins, however, still did not exhibit
A activity, consistent with the observed lack of virus-mediated
emagglutination. Most of the differences (51 out of 69 residues)
etween the S1 subunits of the hemagglutinating GDU and the non-
emagglutinating UU strain are located in the ﬁrst 249 residues of
1. In order to map  the sialic acid binding domain within the S1
ubunit we constructed a S1 chimera (fused to Fc) in which the
1 N-domain (residues 1–249) of the GDU strain was replaced by
hat (residues 1–246) of the UU strain (S1UU−GDU-Fc), as well as the
eciprocal chimera (S1GDU−UU-Fc). Only the S1GDU−UU-Fc protein
as able to agglutinate erythrocytes demonstrating that the sialic
cid binding activity occurs within the N-terminal 249 residues of
he S1 protein (Fig. 3b).
.4. Sialic acid binding activity of the PEDV S protein facilitates
ell entryTo assess the role of cell surface exposed sialic acids in PEDV
nfection, Vero cells were pretreated with neuraminidase prior
o inoculation with different PEDV strains (Fig. 4). The sialic acidNote, Republic of Korea). b) Percentage of infected cells (relative to PBS-treated)
ance was assessed by unpaired one-tailed Student’s test (* = P<0.01). The infection
dependent inﬂuenza A virus (IAV) was  taken along as a positive
control. The neuraminidase pretreatment greatly reduced infec-
tion (6.5 ± 1.1 fold reduction) of the PEDV-GDU strain, to a similar
extent as seen for IAV. No effect of neuraminidase pretreatment
was observed on infection with the PEDV-UU strain. These results
are in accordance with the HA activity of both PEDV strains and
indicate a strain-dependent binding and receptor recruitment of
sialic acid-containing glycoproteins or glycolipids by PEDV spike
proteins during virus entry of Vero cells.
4.5. Functional role of the PEDV N-domain
Our data and those of others indicate that the S protein N-
domain of at least some PEDV strains is dispensable for replication
of PEDV in vitro. The recombinant PEDV-caDR13 mutant lacking a
large part (215 a.a., residues 19–233) of its S protein N-terminal
region replicated with equal efﬁciency in Vero cells as the parental
virus. Slightly smaller deletions in the N-terminal portion of the
PEDV S protein have been documented for the PC177 (197 a.a.,
residues 34–230) as well as the Tottori2 strain (194 a.a., residues
124 W.  Li et al. / Virus Research 226 (2016) 117–127
Fig. 5. Contrasting trypsin-dependency of recombinant PEDV carrying spike proteins from different PEDV isolates. a) PEDV requires proteolysis to activate membrane fusion.
The  pictures show a PEDV-infected cell fusing with neighbouring cells upon trypsin addition. Snapshots from a time-lapse movie of an infected cell culture taken at 3, 16,
27  and 45 min  after addition of trypsin to the culture medium are shown in the following order: upper left, upper right, lower left and lower right, respectively. Pictures
represent an overlay of ﬂuorescence (virus encoded-mEGFP labelled cells [green] and Hoechst 33342 stained nuclei [blue]) and DIC images). b) Recombinant viruses encoding
spike  proteins of PEDV-CV777, PEDV-GDU and the cell-culture adapted DR13 isolate (GB: AF353511, AFP81695.1, JQ023162.1, respectively) were generated in an isogenic
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tackground by targeted RNA recombination, as described before (Wicht et al., 2014
noculated with recombinant viruses (MOI 0.1) in the absence or presence of soyb
ere  ﬁxed at 15 h post infection, nuclei were stained with DAPI (blue) and nuclei a
3–216) (Oka et al., 2014; Masuda et al., 2015). Whereas our
aDR13-based recombinant virus was generated by rational design
sing reverse-genetics, the PC177 deletion mutant most likely
rose as a result of adaptation to Vero cells (Oka et al., 2014). That
his deletion mutant was apparently selected during passaging sug-
ests that the absence of the N-domain might even have provided
n advantage under the used conditions. Intriguingly, the deletion
n the spike protein of the Tottori2 strain was already detected
n RNA sequenced directly from samples of PEDV-positive pigs
howing mild clinical disease, suggesting that this domain is also
ispensable in vivo and may  reduce virus pathogenicity (Masuda
t al., 2015). Yet, the dispensability of this spike domain for virus
eplication may  vary among PEDV strains depending on their ability
o recruit sialic acids as a receptor for entry.
Our observations demonstrate that the sialic acid binding activ-
ty of the S protein facilitates infection by PEDV. The sensitivity to
euraminidase treatment of PEDV-GDU both in infection and in
he HA assay points to sialic acids being used as auxiliary recep-
ors. Different variants of PEDV exhibit different sialic acid binding
otential. Contrary to the GDU strain, virions of the caDR13 and UU
train as well as their S1 proteins lacked the ability to hemaggluti-
ate erythrocytes. Consistently, removal of cell surface sialic acids
rom Vero cells did not affect infection by these two viruses (Fig. 4
nd data not shown). The highly passaged caDR13 strain has accu-
ulated numerous mutations in its spike protein some of which
ay  have changed its cellular receptor binding properties. The
ecent clinical strains GDU and UU have been passaged in cell cul-
ure for 24 and 27 passages, respectively, yet their spike N-domain
equences are identical to those of the original isolates (data not
hown), excluding cell culture adaptation artifacts. The inability of
he UU virus to agglutinate erythrocytes and its independence on
ell surface sialic acids in infection indicates that functional recep-
or recruitment of cell surface sialic acids is not a universal feature
f all PEDV strains. Variations in sialic acid binding activity of the S1
roteins of different PEDV strains were also observed using bovine
ucin by Deng et al., with a recently isolated chinese PEDV vari-nt showing stronger binding afﬁnity than the prototype Belgium
train CV777 (Deng et al., 2016). We  mapped the sialic acid bind-
ng activity to the ﬁrst 246 residues of the S protein by exchanging
he N-domains of GDU and UU S1 proteins in DR13-based viruses.all recombinant viruses the ORF3 gene was replaced by that of GFP. Vero cells were
ypsin inhibitor (SBTI) or trypsin, or in the presence of both, as indicated. The cells
ected cells (GFP; green) were visualized by ﬂuorescence microscopy.
Recombinant viruses carrying such chimeric spike proteins with
opposite sialic acid dependency might clarify the contribution of
sialic acid binding activity to virus propagation in vitro but also
in vivo.
The GDU spike protein has high homology (∼99% amino acid
sequence identity) to the spike protein of the original highly vir-
ulent US strains whereas the UU spike protein (∼94% identity to
original US strain) is of the less virulent S INDEL type (Vlasova et al.,
2014; Wang et al., 2014; Lin et al., 2015). Most of the variation in
the spike proteins of the original virulent US strains and the S INDEL
strains maps to the N-terminal region of the S protein (Wang et al.,
2014; Lee et al., 2010; Vlasova et al., 2014; Hanke et al., 2015). All
amino acid insertions and deletions that characterize the S INDEL
strains occur within this region. The coronavirus spike protein is
highly immunogenic and the main target for neutralizing antibod-
ies. Differences in neutralizing titers of antisera raised against S
proteins of different PEDV subtypes correlated with variation in
these spike proteins (Wang et al., 2015). Antigenic variation in the
N-domain is consistent with a functional relevance of this domain
of the S protein in vivo and may  have provided the virus evolution-
ary advantage in the evasion from adaptive immune responses. The
inter-strain variation in sialic acid dependence observed for PEDV
has also been seen for viruses of other virus families, including
enterovirus 68, human norovirus and T3 reovirus (Baggen et al.,
2016; Rydell et al., 2009; Dermody et al., 1990) though the signif-
icance of this polymorphism is unknown. Clearly, further studies
are needed in vitro and in vivo to functionally assess differences in
sialic acid binding activity of S proteins and their consequences for
virus infection and pathogenesis.
5. Requirements for proteolytic spike protein activation
5.1. PEDV propagation in cell culture depends on supplemental
trypsin
As ﬁrst demonstrated by Hofmann and Wyler, propagation
of PEDV in cultured cells strictly requires the supplementation
of trypsin to the culture medium (Fig. 5) (Hofmann and Wyler,
1988). Yet, cell culture adaptation of PEDV may  result in a
trypsin-independent propagation phenotype, as illustrated by the
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ell-passaged DR13 strain. Analysis of PEDV recombinants carry-
ng spike proteins of trypsin-dependent and trypsin-independent
iruses in an isogenic background demonstrated that the differ-
nces in trypsin dependency were determined by the spike protein
Fig. 5b) (Wicht et al., 2014b; Shirato et al., 2010). Moreover, inclu-
ion of trypsin after the inoculation stage appeared to be required
or cell–cell fusion and syncytia formation (Fig. 5a) (Hofmann and
yler, 1988; Wicht et al., 2014b). These observations suggest a role
f the trypsin in activation of the spike protein’s membrane fusion
otential. In addition to cell entry, proteolysis is also required for
elease of progeny virus from the infected cell (Shirato et al., 2010).
.2. Cleavage required to activate spike fusion function
Fusion of the coronavirus envelope membrane with a host
ell membrane is driven by conformational changes in the spike
rotein. These conformational changes are irreversible and hence
ightly regulated in time and space in order to prevent prema-
ure activation of the fusion protein. Conformational changes in
he spike protein can be initiated by receptor binding as well as
y acidic pH. Similar to other class I viral fusion proteins, the
oronavirus spike protein requires proteolytic processing to acti-
ate its fusion potential. The spikes of a number of coronaviruses,
articularly within the beta- and gammacoronavirus genera, are
leaved during biogenesis in the infected cell at S1/S2 junction
y the subtilisin-like proprotein convertase furin(Belouzard et al.,
012). However, the spike protein of PEDV and many other alpha-
oronaviruses is presented on the virion surface in an uncleaved
orm. Recently, a second, more universal cleavage site (S2′) has
een proposed within the S2 subunit located just upstream of
he fusion peptide for some beta- and gammacoronavirus spike
roteins including that of MERS-CoV, SARS-CoV, MHV  and IBV
Belouzard et al., 2012; Burkard et al., 2014; Heald-Sargent and
allagher, 2012; Millet and Whittaker, 2014). This cleavage is
hought to occur at the cell surface or in the endosome compart-
ent during virus-cell entry. PEDV is an excellent model virus to
tudy proteolytic activation of coronavirus spike proteins, given
ts unique requirement for supplemental trypsin(-like) proteases
or infection in cell culture (68). We  and others have shown that
his proteolytic activation by trypsin proteases only occurred after
he receptor binding stage (Millet and Whittaker, 2014; Shirato
t al., 2011b; Wicht et al., 2014b). Treatment of virions or cells with
rypsin prior to receptor binding did not rescue infectivity (Wicht
t al., 2014a). This indicates that the trypsin cleavage site within
he PEDV S protein is inaccessible on the virion, in contrast to other
lass I viral fusion proteins including inﬂuenza virus hemagglutinin
hich can be proteolytically primed at any stage after folding. The
ependency on virus-cell interaction for exposure of the S protein
leavage site might prevent premature triggering of the S pro-
ein fusion machinery in the protease-rich intestine. Introduction
f a furin cleavage site in the PEDV S protein by a single valine-
o-arginine substitution (V888R) at a position N-terminal of the
redicted fusion peptide yielded a mutant virus exhibiting trypsin-
ndependent membrane fusion (Li et al., 2015). This observation
urther supports the hypothesis that cleavage just upstream of the
usion peptide is a general and essential requirement for activation
f the CoV spike protein’s membrane fusion function (Belouzard
t al., 2009; Yamada and Liu, 2009; Millet and Whittaker, 2014).
.3. Cleavage as tropism determinant
Replication of PEDV seems to be restricted to the entero-
ytes of the intestinal epithelium. Multiple factors may  determine
irus tropism including in particular the availability of functional
eceptors and fusion-activating proteases. Alterations in cleavage
equirements can have a profound effect on tissue tropism and226 (2016) 117–127 125
pathogenicity of viruses. The highly pathogenic phenotype of avian
inﬂuenza viruses is largely determined by the acquisition of a multi-
basic cleavage site in the HA protein which switches processing of
the hemagglutinin protein by tissue resident trypsin-like proteases
to the ubiquitously expressed furin-like proteases (Millet and
Whittaker, 2014; Yamada and Liu, 2009). The strict requirement
of PEDV for supplemental trypsin proteases during its cell entry
and release are likely met  in vivo by intestine-resident proteases.
Gastric and pancreatic proteases or proteases locally expressed by
intestinal epithelial cells may  facilitate these processes essential
for PEDV infection in the animal host (Zamolodchikova, 2012) and
hence limit its tropism to the enteric tract.
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